Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Yizhong Pharmaceutical Co., Ltd.

Clinical trials sponsored by Shanghai Yizhong Pharmaceutical Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for pancreatic cancer: novel drug combo enters final trial phase Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New hope for pancreatic cancer: novel drug combo enters final trial phase

Disease control Recruiting now

This Phase 3 trial is testing whether a new formulation of the chemotherapy drug paclitaxel, given with gemcitabine, works better than the current standard treatment for metastatic pancreatic cancer. The study will enroll 416 adults who have not yet received treatment for their a…

Phase 3 • Sponsor: Shanghai Yizhong Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 09:03 UTC